| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Al-Gazali syndrome |
Pathogenic |
rs786200938, rs1360531002, rs763080896 |
RCV004821343 RCV001089597 RCV001089599 |
| B3GALT6-related disorder |
Likely pathogenic; Pathogenic |
rs778123798, rs786200938 |
RCV004754826 RCV003944971 |
| Ehlers-Danlos syndrome, spondylodysplastic type, 2 |
Likely pathogenic; Pathogenic |
rs778123798, rs969701761, rs2521960362, rs1638540007, rs786200938, rs1553151294, rs397514720, rs397514721, rs533071750, rs1638566519, rs1638539773 |
RCV002010337 RCV001378837 RCV002007594 RCV003074887 RCV003780941 RCV004821343 RCV001090033 RCV001853073 RCV001853074 RCV000054397 RCV000054398 RCV001290345 RCV001290346 |
| Spondyloepimetaphyseal dysplasia with joint laxity |
Likely pathogenic; Pathogenic |
rs778123798, rs969701761, rs2521960362, rs1638540007, rs786200938, rs397514720, rs397514721 |
RCV002010337 RCV001378837 RCV002007594 RCV003074887 RCV003780941 RCV001853073 RCV001853074 RCV003764726 |
| Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures |
Pathogenic |
rs1553151294, rs397514723, rs397514724, rs786200943 |
RCV001090032 RCV000054401 RCV000054402 RCV000054403 |
| Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures |
Pathogenic; Likely pathogenic |
rs786200938, rs1553151294, rs397514718, rs786200939, rs397514719, rs397514720, rs397514723 |
RCV004821343 RCV000625553 RCV000054390 RCV000054392 RCV000054393 RCV000054394 RCV000054395 RCV003225928 |
| Spondyloepiphyseal dysplasia |
Likely pathogenic |
rs1239366051 |
RCV000825512 |